We looked for correlations of EGFR amplification and/or NFKBIA deletion and overall survival (OS): four GBM were excluded from analysis as the patients died early after diagnosis for reasons unrelated to tumor progression. This evidence concerns the gene NFKBIA and glioblastoma.